- Home
- GOSS vs BLNK Comparison
GOSS vs BLNK Comparison
Compare GOSS & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- BLNK
- Stock Information
- Founded
- GOSS 2015
- BLNK 2009
- Country
- GOSS United States
- BLNK United States
- Employees
- GOSS N/A
- BLNK N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- BLNK Industrial Specialties
- Sector
- GOSS Health Care
- BLNK Consumer Discretionary
- Exchange
- GOSS Nasdaq
- BLNK Nasdaq
- Market Cap
- GOSS 246.6M
- BLNK 295.1M
- IPO Year
- GOSS 2019
- BLNK N/A
- Fundamental
- Price
- GOSS $0.91
- BLNK $1.57
- Analyst Decision
- GOSS Strong Buy
- BLNK Strong Buy
- Analyst Count
- GOSS 5
- BLNK 8
- Target Price
- GOSS $9.20
- BLNK $6.13
- AVG Volume (30 Days)
- GOSS 813.7K
- BLNK 4.8M
- Earning Date
- GOSS 08-12-2024
- BLNK 08-07-2024
- Dividend Yield
- GOSS N/A
- BLNK N/A
- EPS Growth
- GOSS N/A
- BLNK N/A
- EPS
- GOSS N/A
- BLNK N/A
- Revenue
- GOSS $95,842,000.00
- BLNK $156,918,000.00
- Revenue This Year
- GOSS N/A
- BLNK $6.96
- Revenue Next Year
- GOSS N/A
- BLNK $31.64
- P/E Ratio
- GOSS N/A
- BLNK N/A
- Revenue Growth
- GOSS N/A
- BLNK 66.29
- 52 Week Low
- GOSS $0.45
- BLNK $1.56
- 52 Week High
- GOSS $1.60
- BLNK $4.66
- Technical
- Relative Strength Index (RSI)
- GOSS 51.22
- BLNK 25.53
- Support Level
- GOSS $0.83
- BLNK $2.00
- Resistance Level
- GOSS $0.93
- BLNK $1.94
- Average True Range (ATR)
- GOSS 0.08
- BLNK 0.10
- MACD
- GOSS 0.01
- BLNK -0.01
- Stochastic Oscillator
- GOSS 58.05
- BLNK 1.69
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.